Journal
FUTURE MICROBIOLOGY
Volume 3, Issue 3, Pages 275-278Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17460913.3.3.275
Keywords
dendritic cells; dermal injection; malaria; Plasmodium; skin; sporozoite; T-cell priming; vaccine
Categories
Funding
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056840, R01AI044375] Funding Source: NIH RePORTER
- NIAID NIH HHS [R01 AI056840, R01 AI044375] Funding Source: Medline
Ask authors/readers for more resources
Plasmodium sporozoites, the infective stage of the malaria parasite, are injected into the mammalian host by mosquitoes and travel to the liver where they invade hepatocytes. Recent studies demonstrating that sporozoites are inoculated into the skin, remain there for hours before exiting and that 20% of the inoculum goes to the lymph node draining the inoculation site, suggest that there is a 'skin stage' to malaria infection that may set the stage for subsequent host responses to the parasite. Here, we present an overview of what is currently known about sporozoite-host interactions at the inoculation site and the draining lymph node, and discuss the impact of the skin stage of malaria on immunity to pre-erythrocytic stages and malaria vaccine design.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available